Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT ID: NCT06967207
Last Updated: 2025-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
625 participants
OBSERVATIONAL
2025-04-15
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS
NCT05207202
Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability
NCT06430554
Early PP Monitored by EIT in Patients With ARDS
NCT05822869
Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes
NCT06958770
Determine the Effect of Prone Positioning in Adults With ARDS by Electrical Impedance Tomography
NCT04725227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARDS Patients for Training cohort
Training cohort
Not applicable- observational study
Not applicable- observational study
ARDS Patients for Validation cohort
Validation cohort
Not applicable- observational study
Not applicable- observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not applicable- observational study
Not applicable- observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18-80 years
Exclusion Criteria
2. Metastatic cancer (active malignancy with distant metastases);
3. Severe psychiatric disorders;
4. Pregnancy or postpartum status;
5. Pneumothorax or moderate to large pleural effusion without adequate drainage;
6. Chronic respiratory failure;
7. Patients with pulmonary embolism or pulmonary hypertension;
8. Heart failure patients: EF \<50% or NYHA class III or IV;
9. Patient/family refusal to participate;
10. Participation in another interventional trial within 3 months prior to enrollment
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
XiaoJing Zou,MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
XiaoJing Zou,MD
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Critical Care Medicine, Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Department of Critical Care Medicine, Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Department of
Wuhan, Hubei, China
Department of Emergency, Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EIT20250331
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.